With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.
Amid the chaos of the pandemic’s early days, doctors who faced the first coronavirus onslaught reached across oceans and language barriers in an unprecedented effort to advise colleagues trying to save lives in the dark.
A virologist helped crack an impossible problem: how to insure against the economic fallout from devastating viral outbreaks. The plan was ingenious. Yet we're still in this mess.
A health worker wearing Ebola protection gear at a Biosecure Emergency Care Unit treatment center in Beni, Democratic Republic of Congo.CreditCreditBaz Ratner/Reuters
Donald G. McNeil Jr. - NYTimes - August 12th 2019
In a development that transforms the fight against Ebola, two experimental treatments are working so well that they will now be offered to all patients in the Democratic Republic of Congo, scientists announced on Monday.
The antibody-based treatments are quite powerful — “Now we can say that 90 percent can come out of treatment cured,” one scientist said — that they raise hopes that the disastrous epidemic in eastern Congo can soon be stopped and future outbreaks more easily contained.
Recent Comments